- Home
- PHAR vs KIDS Comparison
PHAR vs KIDS Comparison
Compare PHAR & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAR | KIDS |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 437.6M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PHAR | KIDS |
|---|---|---|
| Price | $15.55 | $17.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $39.00 | $24.67 |
| AVG Volume (30 Days) | 20.2K | ★ 128.6K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $98,049,000.00 |
| Revenue This Year | $10.04 | $14.07 |
| Revenue Next Year | $2.70 | $11.85 |
| P/E Ratio | $3,041.22 | ★ N/A |
| Revenue Growth | N/A | ★ 37.95 |
| 52 Week Low | $7.50 | $15.34 |
| 52 Week High | $21.34 | $26.40 |
Technical Indicators
Market Signals| Indicator | PHAR | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 45.67 |
| Support Level | $12.98 | $16.11 |
| Resistance Level | $17.41 | $17.56 |
| Average True Range (ATR) | 0.70 | 1.03 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 34.40 | 14.00 |
Price Performance
Historical ComparisonAbout PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.